Previous close | 3.3400 |
Open | 3.6500 |
Bid | 3.6500 |
Ask | 4.0000 |
Strike | 16.50 |
Expiry date | 2024-07-12 |
Day's range | 3.6500 - 3.6500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Novavax stock has pulled back after hitting a nearly two-year high earlier this month. Is NVAX stock a buy right now?
The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 61,760 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.